Clinical Trial Update: Use of Vitamin D3 for the Treatment of Steroid Resistant Asthmatic Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating vitamin D3 for steroid-resistant asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Florida Atlantic University | Conditions: Asthma | Phase 2 | Status: WITHDRAWN